Key Details
Annual Revenue
$23.61 MAnnual EPS
-$1.42Annual ROE
-273.17%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 11, 2023Recent annual earnings:
Mar 30, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
May 26, 2021Analyst ratings
Recent major analysts updates
01 June '23 Oppenheimer
Perform16 May '23 Oppenheimer
Outperform31 Mar '23 Cantor Fitzgerald
Overweight16 Aug '22 HC Wainwright & Co.
Buy19 July '22 Oppenheimer
Outperform24 Sept '21 HC Wainwright & Co.
Buy09 July '21 Cantor Fitzgerald
Overweight14 June '21 HC Wainwright & Co.
Buy04 May '21 HC Wainwright & Co.
Buy22 Apr '21 Roth Capital
BuyScreeners with NOVN included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Novan doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Novan, Inc. (NOVN) Q1 2023 Earnings Call Transcript
NOVN
Seeking Alpha15 May 2023
Novan, Inc. (NASDAQ:NOVN ) Q1 2023 Earnings Conference Call May 15, 2023 8:30 AM ET Company Participants Paula Brown Stafford - Chairman, President & Chief Executive Officer John Donofrio - Executive Vice President & Chief Operating Officer John Gay - Chief Financial Officer Conference Call Participants Oren Livnat - H.C. Wainwright Jeff Jones - Oppenheimer Jonathan Aschoff - Roth Capital Kemp Dolliver - Brookline Capital Markets John Vandermosten - Zacks Operator Hello and welcome to the Novan Inc. Quarterly Update Conference Call and Webcast.
Novan to Report First Quarter 2023 Financial Results on May 15, 2023
NOVN
GlobeNewsWire08 May 2023
DURHAM, N.C., May 08, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its first quarter 2023 financial results on Monday, May 15th. Novan management will host a conference call and live audio webcast to discuss the operational and financial results at 8:30 a.m. ET that same day.
FAQ
- What is the primary business of Novan?
- What is the ticker symbol for Novan?
- Does Novan pay dividends?
- What sector is Novan in?
- What industry is Novan in?
- What country is Novan based in?
- When did Novan go public?
- Is Novan in the S&P 500?
- Is Novan in the NASDAQ 100?
- Is Novan in the Dow Jones?
- When was Novan's last earnings report?
- When does Novan report earnings?
- Should I buy Novan stock now?
What is the primary business of Novan?
Novan, Inc., a medical dermatology company, focuses on developing and commercializing therapeutic products for skin diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was incorporated in 2006 and is headquartered in Durham, North Carolina. On July 17, 2023, Novan, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
What is the ticker symbol for Novan?
The ticker symbol for Novan is NASDAQ:NOVN
Does Novan pay dividends?
No, Novan does not pay dividends
What sector is Novan in?
Novan is in the Healthcare sector
What industry is Novan in?
Novan is in the Biotechnology industry
What country is Novan based in?
Novan is headquartered in United States
When did Novan go public?
Novan's initial public offering (IPO) was on 21 September 2016
Is Novan in the S&P 500?
No, Novan is not included in the S&P 500 index
Is Novan in the NASDAQ 100?
No, Novan is not included in the NASDAQ 100 index
Is Novan in the Dow Jones?
No, Novan is not included in the Dow Jones index
When was Novan's last earnings report?
Novan's most recent earnings report was on 11 August 2023
When does Novan report earnings?
The date for Novan's next earnings report has not been announced yet
Should I buy Novan stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions